ADMA BIOLOGICS, INC. Revenue Other Manufactured Products (Deprecated 2018-01-31)
ADMA BIOLOGICS, INC. (ADMA) reported Revenue Other Manufactured Products (Deprecated 2018-01-31) of $4.01 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Income Statement › Other Income
us-gaap:RevenueOtherManufacturedProducts · last filed 2018-05-14
- ADMA BIOLOGICS, INC. revenue other manufactured products (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $4.01M, a 54.49% increase year-over-year.
- ADMA BIOLOGICS, INC. revenue other manufactured products (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $4.69M, a 61.73% increase year-over-year.
- ADMA BIOLOGICS, INC. revenue other manufactured products (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $2.59M.
- ADMA BIOLOGICS, INC. revenue other manufactured products (deprecated 2018-01-31) for the quarter ending 2016-09-30 was $2.90M.
| Period end | Revenue Other Manufactured Products (Deprecated 2018-01-31) 3 month | Revenue Other Manufactured Products (Deprecated 2018-01-31) 9 month |
|---|---|---|
| 2018-03-31 | $4.01M 10-Q · filed 2018-05-14 | |
| 2017-09-30 | $4.69M 10-Q · filed 2017-11-03 | $10.65M 10-Q · filed 2017-11-03 |
| 2017-03-31 | $2.59M 10-Q · filed 2018-05-14 | |
| 2016-09-30 | $2.90M 10-Q · filed 2017-11-03 | $7.23M 10-Q · filed 2017-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |